FIELD: medicine, hepatology, toxicology, phthisiology. SUBSTANCE: as a hepatoprotector one should apply succinate of 2-ethyl-6- methyl-3- hydroxypyridine named mexidole. Course application of mexidole provides membrane- protector action upon hepatic cells being toxically affected as a result of prolonged application of tuberculostatics. Moreover, mexidole introduction prevents pathological alterations of functional hepatic and pancreatic samples. Capacity of mexidole to prevent progression of cytolysis and cholestasia syndromes correlates with its antioxidant activity. EFFECT: higher efficiency of prophylaxis and correction. 2 ex, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TREATMENT OF OBLITERATING ATHEROSCLEROSIS OF LOWER LIMB VESSELS AND METHOD FOR ITS TREATMENT | 2001 |
|
RU2190404C1 |
AGENT WITH PANCREAS AND HEPATOPROTECTIVE ACTIVITY FOR PARENTERAL ADMINISTRATION | 2017 |
|
RU2662324C1 |
MYELOPROTECTIVE AGENT (3-HYDROXY-6-METHYL-2-ETHYLPYRIDINE SUCCINATE) FOR PROPHYLAXIS AND CORRECTION OF CYTOPENIC SYNDROME | 2001 |
|
RU2193885C1 |
ANTIOXIDANT, ANTIHYPERGLYCEMIC, HYPOLIPIDEMIC AND ANTISHOCK N-ACETYLCYSTEINATE 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE | 2006 |
|
RU2357955C2 |
AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
METHOD FOR TREATING CHRONIC HEPATITIS | 2005 |
|
RU2282457C1 |
METHOD FOR REDUCING TOXIC DAMAGE OF RATS' LIVER BY A CARBON TETRACHLORATED | 2018 |
|
RU2678313C1 |
METHOD FOR TREATMENT OF CHRONIC HEPATITIS | 2005 |
|
RU2286792C1 |
APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
HEPATOPROTECTOR | 2007 |
|
RU2325158C1 |
Authors
Dates
2002-09-27—Published
2001-04-20—Filed